MYLAN G 13 (Glimepiride 4 mg)
Pill imprint MYLAN G 13 has been identified as Glimepiride 4 mg.
Glimepiride is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glimepiride 4 mg is not a controlled substance under the Controlled Substance Act (CSA).
Glimepiride
- Imprint:
- MYLAN G 13
- Strength:
- 4 mg
- Color:
- Beige
- Size:
- 10.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-4013
- Inactive Ingredients:
- lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
sodium lauryl sulfate
sodium starch glycolate type A potato
D&C Red No. 27
D&C Yellow No. 10
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0426 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More about glimepiride
Consumer resources
- Other brands: Amaryl
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
